Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
風濕免疫科標準病歷範本 Case 一: 【Allopurinol allergy】 Chief Complaints: Rash, fever, and malaise for two days. Present illness: This 52-year-old man suffered from acute painful swelling in his big toe 5 weeks earlier, for which he was treated with ibuprofen followed by allopurinol 200 mg daily. Then his serum urate concentration was 8.5 mg/dl and serum creatinine concentration 2.5 mg/dl. He noted a widespread rash, oral and genital ulceration, fever, malaise, diarrhoea, and diminished urine output 5 days before this entry. Then he was sent to out ER. On examination he was feverish and unwell. His face was red and edematous, and he had blistering on his hands and feet, superficial ulceration in the mouth and conjunctiva, and balanitis. He had a morbilliform rash over his trunk and limbs. The white cell count was 17 × 109/l with 70% neutrophils and 12% eosinophils. Alanine aminotransferase concentration was 143 U/l (normal <31), and the creatinine concentration had risen to 5.5 mg/dl. Under the impression of allopurinol related Stevens-Johnson syndrome, he was admitted for further management. Impression: 1. Steven-Johnson syndrome, allopurinol related, with hepatitis and acute on chronic renal failure. 2. Gout Plans: 1. Diagnostic plan Check IgE, ANA, septic workup 2. Therapeutic plan Systemic steroid, close monitor skin, renal, liver function Adequate Hydration and nutrition Consult Oph IVIG if necessary 3. Education plan Skin care, stop allopurinol Case 二: 【Stevens-Johnson syndrome (SJS)/TEN overlap induced by carbamazepine】 Chief Complaints: Generalized skin rash for 1 day. Present illness: This 28-year-old woman had history of childhood epilepsy and was on antiepileptic medication previously until the age of nine years. She was unable to provide the name of the medication. She was started on carbamazepine 15 days before this entry for recurrence of seizures. She developed a macular rash, fever and mouth ulcers 2 days before this entry. The rash started on the face and progressed rapidly to her trunk and limbs over the next day. The facial rash subsequently evolved into pustules, which also erupted over her neck and chest within 24 hours. She was sent to our ER for further management. Clinical examination of the skin revealed a generalized erythematous macular rash, confluent over the trunk and back. Nikolsky’s sign was positive. Targetoid lesions were noted over the thighs and upper limbs, including palms and soles, some of which had central clear bullae. The total extent of the erythematous rash was 55% body surface area (BSA) and bullae accounted for 1% BSA. Of note, there were confluent lakes of pustules over the face. Non-follicular pustules were also noted over the neck and the chest. There were multiple erosions over the mouth and vulva, and her conjunctiva was inflamed. She was febrile. There was no hepatosplenomegaly or lymphadenopathy. Her total white blood cell count was 4 × 109/L. No atypical lymphocytosis or eosinophilia was noted. She had mild transaminitis, alkaline phosphatase (ALP) 181 U/L, alanine aminotransferase (ALT) 176 U/L, aspartate aminotransferase (AST) 140 U/L. The clinical impression was Stevens-Johnson syndrome (SJS)/TEN overlap induced by carbamazepine. Then she was admitted. Imp: 1. Stevens-Johnson syndrome (SJS)/TEN overlap induced by carbamazepine 2. Seizure disorder Plans: 1. Diagnostic plan Check IgE, ANA, septic workup 2. Therapeutic plan Systemic steroid, close monitor skin, renal, liver function Adequate Hydration and nutrition Consult Oph; Neurologist (alternative anti-seizure medication) IVIG if necessary 3. Education plan Skin care, stop carbamazepine Case 三: 【Septic arthritis in a Rheumatoid arthritis patient receiving anti-Tumor Necrosis Factor agent】 Chief Complaints: Painful swelling, redness in right ankle for 2 days Present Illness: A 65-year-old man had a 6-year history of rheumatoid arthritis with medications included daily administration of 7.5 mg prednisolone, 1000 mg salazosulfapyridine, 300 mg sulindac, and weekly 15 mg methotrexate. Eighteen weeks earlier he had started a twice-weekly subcutaneous administration of 25 mg etanercept due to severe RA activity. This was well tolerated and offered sufficient control of disease activity. Before administration of etanercept, C-reactive protein (CRP) levels were 83 mg/l, erythrocyte sedimentation rate (ESR) was 100 mm/h, and DAS284 was 5.17. Hepatitis B and C serology were negative, and tuberculin skin testing was positive. Inflammatory signs decreased after administration of etanercept, the levels of CRP were 3.4 mg/l, ESR was 17 mm/h, and DAS28 was 3.31. The patient experienced a 2-day history of swelling, redness, and worsening pain in his right ankle. He was afebrile. And he denied trauma history. He was sent to our ER. On initial examination, the patient’s temperature was 36.9°C and pulse and blood pressure were normal. There was tenderness, swelling, and redness of the right ankle joint with a decreased range of motion. Laboratory data revealed a white blood cell count of 12 000/mm3 (segmented neutrophils 84%), a hemoglobin level of 12.0 g/dl, and elevated inflammatory markers (ESR 40 mm/h, CRP 248 mg/l). X-ray films of the right ankle joint revealed spreading of the talotibial joint space and erosive destruction of the subtalar joint. Ten milliliter yellow turbid synovial fluid was aspirated from the ankle for laboratory analysis. He was admitted for further management under the impression of septic arthritis. Impression: Septic arthritis; right ankle; probably related to anti-TNF agent (etanercept) Plans: 1. Diagnostic plan Septic workup; pursue culture report 2. Therapeutic plan Arthrocentesis and joint irrigation if necessary Oxacillin Consult Orthopedics for surgical drainage Stop etanercept 3. Education plan Bed rest; leg elevation; local ice packing. Case四: 【Systemic lupus erythematosus #1】 Chief complaint: Severe pain over small joints of fingers, wrists, knees, hips and ankles for one month Present Illness: A 48-year-old woman with systemic lupus erythematosus (SLE) diagnosed more than 20 years ago presented to our clinic with a history of generalized pain, profound fatigue, oral ulcers, dry eyes and mouth, and hair loss. She complained of severe pain in her fingers, wrists, knees, hips and ankles. She also reported significant morning stiffness and muscle soreness. In the past, she had had immune thrombocytopenic purpura, several deep venous thromboses and an episode of pulmonary embolism. She was taking warfarin (2.5 mg daily), hydroxychloroquine (200 mg twice daily), acetaminophen as required for pain, and prednisone (5 mg/d). The patient was afebrile. There was no overt synovitis, but there was tenderness over her wrists, elbows, knees and ankles. Radiographs of her long bones showed evidence of multiple bone infarcts and avascular necroses. A technetium-99m radionuclide bone scan showed evidence of a healed infarct of the right lunate and lateral femoral condyles. The patient had a prolonged prothrombin time of 18.6 (normal 9.9–13) seconds, an international normalized ratio (INR) of 1.7 (normal 0.9–1.2) and an activated partial thromboplastin time (aPTT) of 56.1 (normal 24.6–34) seconds. The prolonged prothrombin time was consistent with her history of warfarin therapy. The patient was positive for IgG anticardiolipin antibodies (16 [normal < 12] MPL units). She was admitted to the hospital, and diagnostic procedures were performed. Impression: SLE with antiphospholipid syndrome causing multiple avascular necrosis bone infarction Plans 1. Diagnostic plan: Evaluation of SLE disease activity (anti-dsDNA antibody, C3, C4) Check anti-beta2 microglobulin-I antibody 2. Therapeutic plan: Raise dose of warfarin to achieve a therapeutic INR 2-3 3. Educational plan: Avoid sports and activities that may cause injury Report any abnormal bleeding and measure INR regularly Case五: 【Systemic lupus erythematosus #2】 Chief complaint: Dry cough for 2 months Present Illness: A previously healthy 43-year-old woman presented with a 2-month history of dry cough. She denied constitutional symptoms such as fever, malaise, poor appetite, or body weight loss. Physical examination revealed no abnormalities. A chest radiograph showed blunting of the left costophrenic angle, suggesting the presence of pleural effusion. Thoracocentesis yielded 30 ml of odorless milky fluid containing 4,608/mm3 white blood cells with a differential of 59% lymphocytes, 6% neutrophils, 2% eosinophils, and 33% tissue cells. Biochemical analysis of the pleural fluid demonstrated the following: total protein, 7.8 g/dl; lactate dehydrogenase, 228 U/l; glucose, 86 mg/dl; amylase, 29 U/l; cholesterol, 89 mg/dl; and triglyceride, 857 g/dl, supporting the diagnosis of chylothorax. Gram’s stain, acid-fast stain, and culture of bacteria and mycobacteria all gave negative results. Cytology of the pleural fluid was negative for malignant cells. The computed tomographic (CT) scan of chest demonstrated small amounts of left-sided pleural effusion without evidence of pulmonary parenchyma lesion or mediastinal lymphadenopathy. There was no history of antecedent chest trauma or thoracic surgery. Further immunological studies of serum showed positive for antinuclear antibodies (ANA) at a titer of 1:1,280 with diffuse chromatin and fine and large speckled pattern. She was referred to our IMRH OPD, and tests for anti-dsDNA, anti-SSA/Ro, anti-SSB/La, anti-Sm, and anti-RNP antibodies all gave positive results. Under the impression of systemic lupus erythematosus with chylothorax, she was admitted for further evaluation and treatment. Impression: SLE with chylothorax Plans 1. Diagnostic plan: Systemic evaluation of major organ involvement in SLE (CNS, Heart, Gastrointestinal, Kidney, etc) 2. Therapeutic plan: Solumedrol 20mg IV QD and hydroxychloroquine 200mg PO BID 3. Educational plan: Avoid ultraviolet light exposure Case六: 【Systemic lupus erythematosus #3】 Chief complaint: Abdominal pain, nausea and vomiting for 5 days Present Illness: A previously healthy 19-year-old woman presented with a 5-day history of abdominal pain. She described the discomfort as persistent, dull, and diffuse pain that was aggravated by food intake. The associated symptoms included nausea, vomiting, constipation, and abdominal distention. She denied fever, chills, diarrhea, tarry stool passage, or urinary symptoms. There was no history of previous abdominal surgery or gynecologic disorders. On physical examination, she had no skin lesions or lymphadenopathy. Her abdomen was soft with diffuse tenderness and rebounding pain, especially in the right lower quadrant (RLQ) area. There was no guarding or a palpable mass, and bowel sounds were hypoactive. Laboratory work on admission was significant for a low platelet count of 110 × 109/L and a low serum albumin level of 25 g/L. Serum amylase and lipase levels were normal. Urinalysis revealed proteinuria (3+), and urine pregnancy test was negative. Abdominal ultrasonography showed diffuse intestinal wall thickening, moderate ascites, and a target-like lesion in RLQ area, suggesting intussusception. Computed tomography (CT) revealed multi-segmental wall thickening and intestinal dilatation involving gastric antrum, jejunum, ileum, cecum, proximal ascending colon and rectum, and moderate ascites. An ileocecal intussusception was identified without a definite mass or any enlarged lymph nodes. The CT findings suggested the presence of mesenteric vasculitis with ileocecal intussusception. Immunological studies of serum showed positive antinuclear antibodies (ANA) at a titer of 1:640 with homogenous and speckled pattern. Tests for anti-dsDNA, anti-SSA/Ro, and anti-SSB/La antibodies all gave positive results Under the impression of SLE with mesenteric vasculitis causing ileocecal intussusception, she was admitted for further evaluation and treatment. Impression: SLE with mesenteric vasculitis causing ileocecal intussusception Plans 1. Diagnostic plan: Systemic evaluation of major organ involvement in SLE (CNS, Heart, Kidney, etc) 2. Therapeutic plan: Complete bowel rest (NPO, IV fluid supplement) Solumedrol 40mg IV Q6H Closely monitor therapeutic response and abdominal condition 3. Educational plan: Inform the patient and her family about the possible complications of mesenteric vasculitis (bowel necrosis, perforation and peritonitis) Case七: 【Rheumatoid arthritis】 Chief complaint: Painful swelling of left ankle for days. Present Illness: This 25 year-old woman has a past history of rheumatoid arthritis since 2006. She had received disease modifying anti-rheumatic drug therapy including methotrexate and sulphasalazine. She suffered from right hip joint pain and left ankle pain for days. She visited the rheumatology clinic and biologic therapy was suggested for her current disease condition. CXR showed minimal increased lung markings in the bilateral lower lung fields. The inflammatory parameters such as ESR (49 mm/hr) and CRP (25.3 mg/L) were still high. The rheumatoid factor was positive and the chest X-ray showed no active infection. There were no infection symptoms and signs such as fever and chills. Under the impression of rheumatoid arthritis with active disease, she was admitted for biologic therapy. Throughout the disease course, there were no respiratory symptoms or abdominal symptoms and she denied having a drug allergy history. Impression: Rheumatoid arthritis Plans 1. Diagnostic plan: Immunoglobulin G/A/M and rheumatoid factor 2. Therapeutic plan: Mabthera 1000 mg injection 3. Educational plan: Observation of allergic reaction to the drug Case八: 【Ankylosing spondylitis】 Chief complaint: Arthritis exacerbation of right knee and ankle pain for days. Present Illness: This 41 year-old man has a history of ankylosing spondylitis for 5 years. He was followed up at Chi Mei Hospital. He had suffered from painful swelling of right knee and right ankle since September 2007. Despite sulphasalazine therapy, recurrent arthritis was still noticed over the right knee and right ankle. Thus, the patient started to receive Enbrel (etanercept) therapy every two weeks. However, intermittent joint pain was still noticed with such dosage. The pain increased in intensity and the joint stiffness aggravated in recent days. The sonography performed last week showed active proliferative synovitis at right ankle and right 3rd-5th toe joints. It also showed bone erosion at right 4th toe joint. Under the impression of ankylosing spondylitis with exacerbation, he was admitted for biologic therapy. Throughout the disease course, there were no infection symptoms/signs, respiratory symptoms or abdominal symptoms and he denied having a drug allergy history. Impression: Ankylosing spondylitis Plans 1. Diagnostic plan: Inflammatory index including C reactive protein and ESR 2. Therapeutic plan: Enbrel (etanercept) 25 mg subcutaneous injection twice per week. 3. Educational plan: Observation of allergic reaction to the drug Case九: 【Primary Sjögren’s syndrome】 Chief complaint: Respiratory distress, progressive oligouria and leg edema for a period of two weeks. Present Illness: This 57-year-old woman was admitted to our hospital because of chest pain, respiratory distress, progressive oligouria and leg edema for a period of two weeks. The patient had no prodromal fever, rash, sore throat, or diarrhea. Two months prior to this admission, laboratory investigations including blood cell count, serum biochemistry, and urinalysis were all normal. At the emergency room, she was afebrile, hypertensive (blood pressure 170/90 mmHg), having fainter heart sounds, and bilateral leg pitting edema. Local examination revealed eye redness and buccal mucosa dryness with diminished salivary pool at the floor of the mouth. Schirmer’s test was positive (0 mm in 5 min) in both eyes confirming xerophthalmia. Tracing the medical history, she had a daily feeling of dry mouth and a foreign-body sensation in the eye. These symptoms persisted for several years but were so mild that she did not have any medical help. The initial laboratory evaluations disclosed leukocyte count 5,900/mm3 with normal differential, hemoglobulin 9.7g/dl, platelet count 111,000/mm3, BUN 32 mg/dl, creatine 2.1 mg/dl, and C-reactive protein 2.6 mg/dl. The chest radiogram showed marked enlargement of the cardiac silhouette. The presence of moderate to large pericardial fluid was confirmed by echocardiography. The pericardial fluid obtained from pericardiocentesis had the physical characteristics of an exudate (lactic dehydrogenase level 630 IU/ml and leukocyte 87/mm3). The patients reported less symptoms of dyspnea and chest discomfort. Under the impression of primary Sjögren’s syndrome and pericarditis, she was admitted for further evaluation and treatment. Impression: 1. Primary Sjögren’s syndrome 2. Pericarditis 3. Renal insufficiency Plans 1. Diagnostic plan: The cause of pericarditis: cultures of the pericaial fluid for tuberculosis and other microorganisms, cytology of aspirated specimens. The urinalysis and renal biopsy if heavy proteinuria. Coombs tests, coagulation studies, antinuclear antibodies, anti-Ro antibody, anti-double-strand DNA, Smith antigen, Ro/La antigen, and cardiolipin to exclude systemic lupus erythematosus 2. Therapeutic plan: Initial corticosteroid at a dosage of methylprednisolone 240 mg/day 3. Educational plan: Bed rest